Study on the epidemiology of cancer treatment-related osteopenia, clinical practice, and fracture risk using the Japanese medical information database - Study on the epidemiology of cancer treatment-related osteopenia, clinical practice, and fracture risk using the Japanese medical information database

DAIICHI SANKYO CO., LTD.0 个研究点目标入组 47,860 人开始时间: 2022年9月23日最近更新: 2024年9月2日

适应症

试验速览

Major results are shown in the publication

•Patients who meet either of the following criteria are excluded: 1) Male patients with a confirmed diagnosis of breast cancer and female patients with a confirmed diagnosis of prostate cancer during the study period 2) Patients diagnosed with a disease related to reduced bone mineral density during the study period 3) Patients with a confirmed diagnosis of osteoporosis or fracture before the baseline date 4) Patients with at least 2 confirmed diagnosis of osteoporosis and at least one prescription of osteoporosis drug during the pre-baseline period For breast cancer patients, those who meet the following condition are also excluded: 1) Patients with a previous confirmed diagnosis of cancer (recurrent or metastatic cancer) prior to receiving a confirmed diagnosis of cancer for this study

发起方